146 related articles for article (PubMed ID: 31810587)
1. Relationship between SDC1 and cadherin signalling activation in cancer.
Liao S; Liu C; Zhu G; Wang K; Yang Y; Wang C
Pathol Res Pract; 2020 Jan; 216(1):152756. PubMed ID: 31810587
[TBL] [Abstract][Full Text] [Related]
2. Syndecan-1 suppresses epithelial-mesenchymal transition and migration in human oral cancer cells.
Wang X; He J; Zhao X; Qi T; Zhang T; Kong C
Oncol Rep; 2018 Apr; 39(4):1835-1842. PubMed ID: 29484435
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
Yang Y; Tao X; Li CB; Wang CM
Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
[TBL] [Abstract][Full Text] [Related]
4. Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.
Nikolova V; Koo CY; Ibrahim SA; Wang Z; Spillmann D; Dreier R; Kelsch R; Fischgräbe J; Smollich M; Rossi LH; Sibrowski W; Wülfing P; Kiesel L; Yip GW; Götte M
Carcinogenesis; 2009 Mar; 30(3):397-407. PubMed ID: 19126645
[TBL] [Abstract][Full Text] [Related]
5. Restoration of E-cadherin cell-cell junctions requires both expression of E-cadherin and suppression of ERK MAP kinase activation in Ras-transformed breast epithelial cells.
Li Q; Mattingly RR
Neoplasia; 2008 Dec; 10(12):1444-58. PubMed ID: 19048123
[TBL] [Abstract][Full Text] [Related]
6. Formation of E-cadherin-mediated cell-cell adhesion activates AKT and mitogen activated protein kinase via phosphatidylinositol 3 kinase and ligand-independent activation of epidermal growth factor receptor in ovarian cancer cells.
Reddy P; Liu L; Ren C; Lindgren P; Boman K; Shen Y; Lundin E; Ottander U; Rytinki M; Liu K
Mol Endocrinol; 2005 Oct; 19(10):2564-78. PubMed ID: 15928314
[TBL] [Abstract][Full Text] [Related]
7. An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ.
Götte M; Kersting C; Radke I; Kiesel L; Wülfing P
Breast Cancer Res; 2007; 9(1):R8. PubMed ID: 17244359
[TBL] [Abstract][Full Text] [Related]
8.
Liu Z; Jin H; Yang S; Cao H; Zhang Z; Wen B; Zhou S
J Int Med Res; 2020 Aug; 48(8):300060520947883. PubMed ID: 32812461
[TBL] [Abstract][Full Text] [Related]
9. Metformin mediated reversal of epithelial to mesenchymal transition is triggered by epigenetic changes in E-cadherin promoter.
Banerjee P; Surendran H; Chowdhury DR; Prabhakar K; Pal R
J Mol Med (Berl); 2016 Dec; 94(12):1397-1409. PubMed ID: 27534967
[TBL] [Abstract][Full Text] [Related]
10. Cadherins and epithelial-to-mesenchymal transition.
Gheldof A; Berx G
Prog Mol Biol Transl Sci; 2013; 116():317-36. PubMed ID: 23481201
[TBL] [Abstract][Full Text] [Related]
11. High glucose-induced intestinal epithelial barrier damage is aggravated by syndecan-1 destruction and heparanase overexpression.
Qing Q; Zhang S; Chen Y; Li R; Mao H; Chen Q
J Cell Mol Med; 2015 Jun; 19(6):1366-74. PubMed ID: 25702768
[TBL] [Abstract][Full Text] [Related]
12. Cell surface-anchored syndecan-1 ameliorates intestinal inflammation and neutrophil transmigration in ulcerative colitis.
Zhang Y; Wang Z; Liu J; Zhang S; Fei J; Li J; Zhang T; Wang J; Park PW; Chen Y
J Cell Mol Med; 2017 Jan; 21(1):13-25. PubMed ID: 27558380
[TBL] [Abstract][Full Text] [Related]
13. Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation.
Park MK; You HJ; Lee HJ; Kang JH; Oh SH; Kim SY; Lee CH
Eur J Cancer; 2013 May; 49(7):1692-705. PubMed ID: 23290789
[TBL] [Abstract][Full Text] [Related]
14. Syndecan-1 knockdown inhibits glioma cell proliferation and invasion by deregulating a c-src/FAK-associated signaling pathway.
Shi S; Zhong D; Xiao Y; Wang B; Wang W; Zhang F; Huang H
Oncotarget; 2017 Jun; 8(25):40922-40934. PubMed ID: 28422726
[TBL] [Abstract][Full Text] [Related]
15. Cell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomena.
Bryan RT
Philos Trans R Soc Lond B Biol Sci; 2015 Feb; 370(1661):20140042. PubMed ID: 25533099
[TBL] [Abstract][Full Text] [Related]
16. Sdc1 negatively modulates carcinoma cell motility and invasion.
Ishikawa T; Kramer RH
Exp Cell Res; 2010 Apr; 316(6):951-65. PubMed ID: 20036233
[TBL] [Abstract][Full Text] [Related]
17. AP-1 transcription factor complex is a target of signals from both WnT-7a and N-cadherin-dependent cell-cell adhesion complex during the regulation of limb mesenchymal chondrogenesis.
Tufan AC; Daumer KM; DeLise AM; Tuan RS
Exp Cell Res; 2002 Feb; 273(2):197-203. PubMed ID: 11822875
[TBL] [Abstract][Full Text] [Related]
18. E-Cadherin and Syndecan-1 Expression in Patients With Advanced Non-small Cell Lung Cancer Treated With Chemoradiotherapy.
Gkogkou P; Peponi E; Ntaskagiannis D; Murray S; Demou A; Sainis I; Ioakeim E; Briasoulis E; Tsekeris P
In Vivo; 2020; 34(1):453-459. PubMed ID: 31882513
[TBL] [Abstract][Full Text] [Related]
19. Syndecan-1 facilitates breast cancer metastasis to the brain.
Sayyad MR; Puchalapalli M; Vergara NG; Wangensteen SM; Moore M; Mu L; Edwards C; Anderson A; Kall S; Sullivan M; Dozmorov M; Singh J; Idowu MO; Koblinski JE
Breast Cancer Res Treat; 2019 Nov; 178(1):35-49. PubMed ID: 31327090
[TBL] [Abstract][Full Text] [Related]
20. FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer.
Hu X; Zhai Y; Kong P; Cui H; Yan T; Yang J; Qian Y; Ma Y; Wang F; Li H; Cheng C; Zhang L; Jia Z; Li Y; Yang B; Xu E; Wang J; Yang J; Bi Y; Chang L; Wang Y; Zhang Y; Song B; Li G; Shi R; Liu J; Zhang M; Cheng X; Cui Y
Cancer Lett; 2017 Jul; 397():83-93. PubMed ID: 28366557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
